Correlation of Hsp70-1 and Hsp70-2 gene expression with the degree of graft-versus-host reaction in a rat skin explant model

Transplantation

Volumn 85, Issue 12, 2008, Pages 1809-1816

  Novota, Peter ^a   Sviland, Lisbet ^b   Zinöcker, Severin ^c   Stocki, Pawel ^d   Balavarca, Yesilda ^a   Bickeböller, Heike ^a   Rolstad, Bent ^c   Wang, Xiao N ^d   Dickinson, Anne M ^d   Dressel, Ralf ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Animal model; Graft versus host disease; Heat shock protein 70 genes; Major histocompatibility complex; Skin explant assay

Indexed keywords

HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 1; HEAT SHOCK PROTEIN 70 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; MINOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; HEAT SHOCK PROTEIN 72; HSPA1B PROTEIN, RAT;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; EXPLANT; GENE EXPRESSION REGULATION; GENETIC MARKER; GRAFT VERSUS HOST REACTION; HLA MATCHING; IMMUNOASSAY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; ANIMAL; BONE MARROW TRANSPLANTATION; DISEASE MODEL; HISTOCOMPATIBILITY; IMMUNOLOGY; LEWIS RAT; METABOLISM; PREDICTION AND FORECASTING; SKIN; SKIN TRANSPLANTATION;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; HSP70 HEAT-SHOCK PROTEINS; HSP72 HEAT-SHOCK PROTEINS; MAJOR HISTOCOMPATIBILITY COMPLEX; MINOR HISTOCOMPATIBILITY ANTIGENS; MODELS, ANIMAL; PREDICTIVE VALUE OF TESTS; RATS; RATS, INBRED LEW; SKIN; SKIN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 49149102471     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817753f7     Document Type: Article

References (40)

1. Dickinson AM, Middleton PG, Rocha V, et al. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol 2004; 127: 479.
2. DeGast GC, Mickelson EM, Beatty PG, et al. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant 1992; 9: 87.
3. Dickinson AM, Sviland L, Wang XN, et al. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: A comparison of T-cell frequency analysis and a human skin explant model. Transplantation 1998; 66: 857.
4. Theobald M, Nierle T, Bunjes D, et al. Host-specific interleukin-2- secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med 1992; 327: 1613.
5. KaminskiE, Hows J, Man S,et al. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 1989; 48: 608.
6. Roosnek E, Hogendijk S, Zawadynski S, et al. The frequency of pre-transplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings. Transplantation 1993; 56: 691.
7. Fussell ST, Donnellan M, Cooley MA, et al. Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation. Transplantation 1994; 57: 673.
8. Sviland L, Dickinson AM. A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation. J Clin Pathol 1999; 52: 910.
9. Dickinson AM, Cavet J, Cullup H, et al. GvHD risk assessment in hematopoietic stem cell transplantation: role of cytokine gene polymorphisms and anin vitro human skin explant model.Hum Immunol2001; 62: 1266.
10. Sviland L, Dickinson AM, Carey PJ, et al. An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1990; 5: 105.
11. Dickinson A, Hromadnikova I, Sviland L, et al. Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants - Effect of GVHD prophylaxis. Bone Marrow Transplant 1999; 24: 857.
12. Wang XN, Collin M, Sviland L, et al. Skin explant model of human graft-versus-host disease: Prediction of clinical outcome and correlation with biological risk factors. Biol Blood Marrow Transplant2006; 12: 152.
13. Vogelsang GB, Hess AD, Berkman AW, et al. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N Engl J Med 1985; 313: 645.
14. Dickinson A. Predicting graft-versus-host disease in allogeneic bone marrow transplant recipients. Transpl Immunol 1994; 2: 154.
15. HromadnikovaI, Sedlacek P, Stary J,et al.Anin vitro skin explant assay as a predictive assay for graft-versus-host disease in a cohort of pediatric transplants. Pediatr Transplant 2001; 5: 258.
16. Dickinson AM, Wang XN, Sviland L, et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histo-compatibility antigens. Nat Med 2002; 8: 410.
17. Sviland L, Hromadnikova I, Sedlacek P, et al. Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation. Hum Immunol 2001; 62: 1277.
18. Dickinson AM, Sviland L, Hamilton PJ, et al. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 65.
19. Dressel R, Walter L, Günther E. Genomic and functional aspects of the rat MHC, the RT1 complex. Immunol Rev 2001; 184: 82.
20. Günther E, Walter L. The major histocompatibility complex of the rat (Rattus Norvegicus). Immunogenetics 2001; 53: 520.
21. Nestvold JM, Omdal BK, Dai KZ, et al. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Transplantation 2008; 85: 102.
22. Günther E, Walter L. Comparative genomic aspects of rat, mouse and human MHC class I gene regions. Cytogenet Cell Genet 2000; 91: 107.
23. Hurt P, Walter L, Sudbrak R, et al. The genomic sequence and comparative analysis of the rat major histocompatibility complex. Genome Res 2004; 14: 631.
24. Jarvis M, Marzolini M, Wang XN, et al. Heat shock protein 70: Correlation of expression with degree of graft-versus-host response and clinical graft-versus-host disease. Transplantation 2003; 76: 849.
25. Goral J, Mathews HL, Clancy J Jr. Antibodies specific for the 70-kDa heat-shock protein parallel the development of acute graft-versus-host disease in (DAXLEW)F1 rats. Clin Immunol Immunopathol 1995; 75: 147.
26. Goral J, Mathews HL, Clancy J Jr. Expression of 70-kDa heat-shock protein during acute graft-versus-host disease. Clin Immunol Immunopathol 1998; 86: 252.
27. Dressel R, Günther E. Heat-induced expression of MHC-linked HSP70 genes in lymphocytes varies at the single-cell level. J Cell Biochem 1999; 72: 558.
28. Lerner KG, Kao GF, Storb R, et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974; 6: 367.
29. Walter L, Rauh F, Günther E. Comparative analysis of the three major histocompatibility complex-linked heat shock protein 70 (Hsp70) genes of the rat. Immunogenetics 1994; 40: 325.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
31. Weksberg R, Hughes S, Moldovan L, et al. A method for accurate detection of genomic microdeletions using real-time quantitative PCR BMC Genomics 2005; 6: 180.
32. Wang XN, Proctor SJ, Dickinson AM. Frequency analysis of recipient-reactive helper and cytotoxic T lymphocyte precursors using a combined single limiting dilution assay. Transpl Immunol 1996; 4: 247.
33. Goral J, Shenoy S, Mohanakumar T, et al. Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients. Clin Exp Immunol 2002; 127: 553.
34. Günther E, Walter L. Genetic aspects of the hsp70 multigene family in vertebrates. Experientia 1994; 50: 987.
35. Favatier F, Bornman L, Hightower LE, et al. Variation in hsp gene expression and Hsp polymorphism: Do they contribute to differential disease susceptibility and stress tolerance? Cell Stress Chaperones 1997; 2: 141.
36. Bogunia-Kubik K, Lange A. HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease. Transplantation 2005; 79: 815.
37. Bogunia-Kubik K, Uklejewska A, Dickinson A, et al. HSP70-hom gene polymorphism as a prognostic marker of graft-versus-host disease. Transplantation 2006; 82: 1116.
38. Beere HM. Death versus survival: Functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 2005; 115: 2633.
39. Calderwood SK, Theriault JR, Gong J. Message in a bottle: Role of the 70-kDa heat shock protein family in antitumor immunity. Eur J Immunol 2005; 35: 2518.
40. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002; 2: 185.